Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Jan;20(1):88.
doi: 10.1634/theoncologist.2014-0273.

Adjuvant therapy-related shortening of survival (ATRESS): an underrated phenomenon

Michael K Fink  1 , Ulrich R Kleeberg  2 , Stefan Bartels  3
Affiliations
Comment

Adjuvant therapy-related shortening of survival (ATRESS): an underrated phenomenon

Michael K Fink et al. Oncologist. 2015 Jan.

Abstract

Shortening of survival after dissemination following adjuvant treatment is not understood well enough and is difficult to search for in public databases because of the lack of specific search terms. We suggest using the acronym ATRESS, for “adjuvant therapy-related shortening of survival,” in future literature concerning this issue.

PubMed Disclaimer

Comment in

Comment on

References

    1. Seidman AD, Chan S, Wang J, et al. A pooled analysis of gemcitabine plus docetaxel versus capecitabine plus docetaxel in metastatic breast cancer. The Oncologist. 2014;19:443–452. - PMC - PubMed
    1. Kleeberg UR, Fink M, Tessen HW, et al. Adjuvant therapy reduces the benefit of palliative treatment in disseminated breast cancer - own findings and review of the literature. Onkologie. 2013;36:348–356. - PubMed
    1. Pierga J-Y, Asselain B, Jouve M, et al. Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy. Cancer. 2001;91:1079–1089. - PubMed
    1. Giordano SH, Buzdar AU, Smith TL, et al. Is breast cancer survival improving? Cancer. 2004;100:44–52. - PubMed
    1. O’Connell MJ, Campbell ME, Goldberg RM, et al. Survival following recurrence in stage II and III colon cancer: Findings from the ACCENT data set. J Clin Oncol. 2008;26:2336–2341. - PubMed